Home/Filings/5/0001209191-05-007918
5//SEC Filing

JENN PAUL 5

Accession 0001209191-05-007918

CIK 0000920465other

Filed

Feb 8, 7:00 PM ET

Accepted

Feb 9, 4:33 PM ET

Size

13.5 KB

Accession

0001209191-05-007918

Insider Transaction Report

Form 5
Period: 2004-12-31
JENN PAUL
VP of Product Development
Transactions
  • Other

    Common Stock

    2004-06-30$1.48/sh+349$5161,912 total
  • Other

    Common Stock

    2004-09-30$1.48/sh+295$4362,207 total
  • Other

    Common Stock

    2004-12-31$1.42/sh+361$5122,568 total
Holdings
  • Common Stock

    2,568
  • Stock Option (right to buy)

    Common Stock (409,474 underlying)
    409,474
Footnotes (2)
  • [F1]Acquired pursuant to the Company?s Employee Stock Purchase Plan.
  • [F2]Reporting only direct holdings, no transaction data is necessary

Issuer

LA JOLLA PHARMACEUTICAL CO

CIK 0000920465

Entity typeother

Related Parties

1
  • filerCIK 0001237528

Filing Metadata

Form type
5
Filed
Feb 8, 7:00 PM ET
Accepted
Feb 9, 4:33 PM ET
Size
13.5 KB